Account
Articles
23.06.2020
COVID-19 impact on pricing and market access

Without a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...

Read more
Articles
28.05.2020
Scottish Medicines Consortium (SMC)

NICE has announced they will begin a phased restart of publishing guidance, whilst SMC meetings are ...

Read more
Articles
12.05.2020
Price and market access price affected by COVID

We received fabulous feedback, with responses from at least 15 industry executives across global pha...

Read more
Articles
05.05.2020
Remote delivery of market access training

Whilst many businesses are currently working remotely, up-skilling your workforce through interactiv...

Read more
Articles
31.03.2020
The impact of Covid-19 on payer and HTA decisions

Given the shutdown occurring in response to COVID-19, payers and HTA bodies are struggling to adjust...

Read more
Articles
27.03.2020
NICE postpones technology appraisals

NICE confirmed that they will be prioritising work that is therapeutically critical or relates to ad...

Read more
Newer

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch